184 related articles for article (PubMed ID: 17375263)
1. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
3. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Hinton DR; Spee C; He S; Weitz S; Usinger W; LaBree L; Oliver N; Lim JI
Diabetes Care; 2004 Mar; 27(3):758-64. PubMed ID: 14988298
[TBL] [Abstract][Full Text] [Related]
6. Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Acta Ophthalmol; 2012 Mar; 90(2):e84-9. PubMed ID: 22103573
[TBL] [Abstract][Full Text] [Related]
7. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
Kuiper EJ; de Smet MD; van Meurs JC; Tan HS; Tanck MW; Oliver N; van Nieuwenhoven FA; Goldschmeding R; Schlingemann RO
Arch Ophthalmol; 2006 Oct; 124(10):1457-62. PubMed ID: 17030714
[TBL] [Abstract][Full Text] [Related]
8. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
[TBL] [Abstract][Full Text] [Related]
9. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.
El-Asrar AM; Missotten L; Geboes K
Mol Vis; 2011 Feb; 17():508-18. PubMed ID: 21365018
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.
Kuiper EJ; Witmer AN; Klaassen I; Oliver N; Goldschmeding R; Schlingemann RO
Br J Ophthalmol; 2004 Aug; 88(8):1082-7. PubMed ID: 15258030
[TBL] [Abstract][Full Text] [Related]
11. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
12. Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.
Dong Z; Kase S; Ando R; Fukuhara J; Saito W; Kanda A; Murata M; Noda K; Ishida S
Retina; 2012 Jun; 32(6):1190-6. PubMed ID: 22371118
[TBL] [Abstract][Full Text] [Related]
13. In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.
Boneva SK; Wolf J; Hajdú RI; Prinz G; Salié H; Schlecht A; Killmer S; Laich Y; Faatz H; Lommatzsch A; Busch M; Bucher F; Stahl A; Böhringer D; Bengsch B; Schlunck G; Agostini H; Lange CAK
Front Immunol; 2021; 12():757607. PubMed ID: 34795670
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
15. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes.
Abu El-Asrar AM; Struyf S; Verbeke H; Van Damme J; Geboes K
Acta Ophthalmol; 2011 May; 89(3):222-8. PubMed ID: 19764917
[TBL] [Abstract][Full Text] [Related]
16. The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.
Kuiper EJ; Van Nieuwenhoven FA; de Smet MD; van Meurs JC; Tanck MW; Oliver N; Klaassen I; Van Noorden CJ; Goldschmeding R; Schlingemann RO
PLoS One; 2008 Jul; 3(7):e2675. PubMed ID: 18628999
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.
Zhang X; Yu W; Dong F
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):661-8. PubMed ID: 22160564
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
Abu El-Asrar AM; Siddiquei MM; Nawaz MI; De Hertogh G; Mohammad G; Alam K; Mousa A; Opdenakker G
Mol Vis; 2016; 22():424-35. PubMed ID: 27168718
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders.
Abu El-Asrar AM; De Hertogh G; Allegaert E; Nawaz MI; Abouelasrar Salama S; Gikandi PW; Opdenakker G; Struyf S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686317
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 studies in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
